Biocept Inc. (NASDAQ:BIOC) has a beta value of 0.77 and has seen 0.47 million shares traded in the last trading session. The company, currently valued at $55.41M, closed the last trade at $3.66 per share which meant it lost -$0.1 on the day or -2.66% during that session. The BIOC stock price is -128.96% off its 52-week high price of $8.38 and 10.93% above the 52-week low of $3.26. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.37 million shares traded. The 3-month trading volume is 1.14 million shares.
The consensus among analysts is that Biocept Inc. (BIOC) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Biocept Inc. (NASDAQ:BIOC) trade information
Sporting -2.66% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the BIOC stock price touched $3.66 or saw a rise of 4.69%. Year-to-date, Biocept Inc. shares have moved -17.57%, while the 5-day performance has seen it change 4.27%. Over the past 30 days, the shares of Biocept Inc. (NASDAQ:BIOC) have changed -8.50%. Short interest in the company has seen 0.78 million shares shorted with days to cover at 2.06.
Wall Street analysts have a consensus price target for the stock at $12.00, which means that the shares’ value could jump 69.5% from current levels. The projected low price target is $12.00 while the price target rests at a high of $12.00. In that case, then, we find that the current price level is -227.87% off the targeted high while a plunge would see the stock gain -227.87% from current levels.
Biocept Inc. (BIOC) estimates and forecasts
The company’s shares have lost -28.24% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 110.50%.
1 analysts offering their estimates for the company have set an average revenue estimate of $17.76 million for the current quarter. 1 have an estimated revenue figure of $12.05 million for the next quarter concluding in Jun 2021. Year-ago sales stood $1.45 million and $917k respectively for this quarter and the next, and analysts expect sales will grow by 1,127.10% for the current quarter and 1,213.70% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 72.30% over the past 5 years. Earnings growth for 2021 is a modest 87.70% while over the next 5 years, the company’s earnings are expected to increase by 40.00%.
Biocept Inc. is expected to release its next earnings report between November 10 and November 15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Biocept Inc. (NASDAQ:BIOC)’s Major holders
Insiders own 0.04% of the company shares, while shares held by institutions stand at 10.83% with a share float percentage of 10.83%. Investors are also buoyed by the number of investors in a company, with Biocept Inc. having a total of 26 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 0.66 million shares worth more than $2.76 million. As of Jun 29, 2021, Vanguard Group, Inc. (The) held 4.47% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 0.19 million shares as of Jun 29, 2021. The firm’s total holdings are worth over $0.81 million and represent 1.31% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Mar 30, 2021, the former fund manager holds about 2.94% shares in the company for having 0.43 million shares of worth $2.2 million while later fund manager owns 0.22 million shares of worth $1.11 million as of Mar 30, 2021, which makes it owner of about 1.49% of company’s outstanding stock.